Aegon's Stock Plummets 10% at Close Following Announcement of U.S. Relocation
Aegon's shares experienced a significant drop following the announcement of its strategic transformation and relocation to the United States, coupled with conservative financial targets.
Significant Drop in Share Price
AEGON's shares plunged by 8% this Wednesday in Amsterdam, closing the session at 6.186 euros, marking a decline of 10.11% from the previous day's close of 6.88 euros. This correction represents the steepest weekly drop for the group, with the shares now down 10.09% over seven days. The annual performance is limited to a modest gain of 0.91%, far from the expectations set by previously announced share buybacks. Trading volumes were substantial, accounting for 1.96% of the capital, indicating a massive sell-off by investors. Over three months, the decline has now reached 5.56%, signaling a sustained technical reversal. The insurer has set new financial targets and announced a 400 million euro share buyback program for 2026, aiming also for a dividend growth of over 5% per year. However, the market harshly penalized these announcements, deemed too conservative.
Headquarters and Legal Base Moving to the U.S.
The insurer confirmed its plan to move its headquarters and legal base to the United States as part of a multi-year restructuring, with the transition expected to be completed by January 1, 2028, and the company will adopt the name Transamerica. This major strategic transformation aims to focus resources on the American market, which already accounts for about 70% of the group's activity. The transition is expected to incur a one-time implementation cost of approximately 350 million euros to be borne between the second half of 2025 and the first half of 2028. This exceptional charge is weighing on investors' calculations, who are scrutinizing short-term profitability. Technical indicators paint a concerning picture. The RSI (Relative Strength Index) was at 70 before the session, indicating an overbought zone that made a correction likely. The stock is now significantly below its 50-day moving average, positioned at 6.66 euros, which is 7.8% above the current price. The MACD, with both a signal line and a MACD line at 0.08 and a histogram at zero, already indicated a lack of clear upward momentum. The support threshold identified at 6.52 euros was breached at the close, opening the way for a potential retreat towards the 200-day moving average established at 6.57 euros, the last major technical barrier.
Additional Investment in U.S. Operations
Aegon is allocating an additional 800 million euros to its American operations to support risk reduction measures related to a reinsurance agreement on its SGUL portfolio, with management anticipating that the operating result will increase by about 5% in 2026 and 2027. This moderate growth ambition is not enough to convince the market, which expected more dynamic prospects to justify the ongoing organizational upheaval. The Bollinger Bands frame the price between 6.48 euros (lower bound) and 7.04 euros (upper bound), placing the stock in the lower part of its channel after this sharp downturn. The monthly volatility of the stock, established at 5.93, shows a significant range of fluctuations in a context of profound transformation. The negative beta coefficient of -0.15 indicates an inverse correlation with the market, suggesting that AEGON is moving according to its own dynamics, largely dictated by its internal strategic decisions. Despite the decline, flow indicators remain positive, with an OBV (On Balance Volume) at 29.7 million and a CMF (Chaikin Money Flow) at 0.12, indicating underlying accumulation. This divergence could foreshadow a rebound if support levels hold in the upcoming sessions. The major resistance at 6.95 euros must be reconquered to consider a sustainable reversal of the trend.
